Company Updates

LPPFusion Faces Uphill Battle to Secure Funding

With its controversial founder and unpopular scientific approach, LPPFusion is a risky investment that faces an uphill funding battle.
Featured Image

Funding Round Details

LPPFusion logo
Company: LPPFusion
Security Type: Equity - Common
Valuation: $67,920,000
Min Investment: $200
Platform: Wefunder
Deadline: Dec 15, 2023
View Deal

Moonshot companies are a tough sell for investors. These kinds of startups typically need large amounts of funding to show results, but investors usually want to see early results before they take the risk of investing.

For LPPFusion, the risks and returns are higher than most moonshot investment opportunities. So it’s even more difficult for the company to raise the funds it needs to get initial results.

LPPFusion is trying to create fusion energy, a harmless radioactive reaction that can theoretically produce a virtually limitless amount of energy — and could completely decarbonize the grid. Scientists have been working on creating fusion energy for decades but are still at least 10 years away (or more) from solving the technological problems associated with it and reaching commercialization. But if they succeed, they could create enough energy to power the world’s grids and energy-intensive technologies like quantum computers.

KingsCrowd rated LPPFusion a Deal to Watch in 2020. Since 2018, the company has raised more than $2.4 million online — a great number for an equity crowdfunding company, but very low for such a risky moonshot. Let’s explore LPPFusion’s progress and the risks that investors should consider if they want to invest in the company.

Creating the Sun on Earth

First, let’s break down fission and fusion. Atoms are made of a center, called a nucleus, which is a combination of neutrons and protons. Traditional nuclear technology, called fission, generates energy by adding a neutron to a nucleus and splitting it into two nuclei. This creates unstable nuclei and generates both heat and radioactivity.

Fusion is the opposite of fission. It combines two or more nuclei together into one larger one. The only byproducts are helium and a fast and hot neutron that will heat water and produce steam. Fusion can be used to produce electricity. And since fusion is not meant to produce radioactivity, it is theoretically less dangerous than fission.

There are several theories on the right way to produce fusion reactions. The most common method is laser fusion technology, which can create a similar temperature and pressure as the one that exists in the stars. It is the only method that has produced significant results so far. And only the public Lawrence Livermore National Laboratory (LLNL) — which has an annual budget of more than $2.2 billion — has managed to produce energy with fusion technology. No private company has managed to generate positive results yet.

LPPFusion uses a different technology called dense plasma focus (DPF). DPF technology compresses plasma until it creates an intense ray of neutrons. LPPFusion is one of the only projects using this technology. 

An Impossible Equation

This is where the vicious cycle of needing funding and needing results begins. Most government agencies — including the U.S. government — do not believe DPF is a viable pathway to create fusion. DPF’s effectiveness has historically been discounted after decades of research achieved no results. So LPPFusion has had difficulties raising funds in order to prove naysayers wrong. 

The company is still proud of its recent results. A recent peer review confirmed that LPPFusion has the best energy output/input ratio of all private companies trying the DPF method. This peer review estimates that if it gets enough funding, LPPFusion could achieve positive results with a prototype between 2026 and 2030. 

LPPFusion has an ambitious goal to achieve positive net energy — similar to LLNL — by 2024. According to LPPFusion founder and CEO Eric Lerner, if the company achieves this goal, it will need $100 million to create its prototype. 

But right now, LPPFusion faces two major funding risks. 

First, most projects trying to create fusion energy are using laser technology. Investors backing LPPFusion’s DPF technology are taking a pretty high risk by backing a technology that most would not fund. So they may be reluctant to back the company.

Second, a good fundraiser is a founder who can convince investors. And Lerner could do better at this. While he is very smart, he has a very divisive personality. He dropped his graduate studies because he did not like the academic approach. He wrote a book criticizing the methods behind the Big Bang theory. And now he’s building a startup based on a technology that most scientists have abandoned.

He might be right. No one will know for sure unless/until he reaches a breakthrough. But in the meantime, I fear that investors will not want to invest in him because of his divisive background and controversial reputation in the industry — and the fact that the U.S. government refuses to back his work. Having such a divisive founder leading one of the biggest moonshots available on equity crowdfunding platforms makes LPPFusion a very risky investment. 

Léa Bouhelier-Gautreau
About: Léa Bouhelier-Gautreau

Léa is passionate about impact investing and sustainability. Prior to KingsCrowd, she worked for Stanford’s accelerator, StartX, helping to select the most promising entrepreneurs. She also led the first award-winning study on the Malawian startup ecosystem. In her free-time, she volunteers to help entrepreneurs in Cameroon, Brazil and Colombia. Léa holds a degree in Anthropology from France and is currently enrolled in the UC Davis MBA program.

Recent Posts

KingsCrowd and Radivision® Partner to Support New Startup Funding and Private Market Investing

Data plus content empower Main Street investors’ private market access and wealth creation

Brian Belley
Brian Belley Jun 12, 2024
Market News
KingsCrowd and Radivision® Partner to Support New Startup Funding and Private Market Investing

Innovation in Auto-Injectors: Pirouette Medical’s Journey with Conor Cullinane

Tune in as Conor Cullinane, Founder & CEO of Pirouette Medical, discusses how his startup is transforming medication delivery systems on Inside Startup Investing. Discover the inspiration and technology behind their groundbreaking auto-injector.

Jun 10, 2024
Innovation in Auto-Injectors: Pirouette Medical’s Journey with Conor Cullinane

Follow-On Funding Round Performance in Reg CF

A data-driven analysis of companies that have raised multiple Reg CF rounds to explore whether companies tend to raise more or less in follow-on funding rounds.

Teddy Lyons
Teddy Lyons Jun 9, 2024
Industry Analysis
Follow-On Funding Round Performance in Reg CF

Take your startup investing to the next level with powerful data and expert analysis from KingsCrowd.

Get a free weekly Pitch Review!

Sign up for our 3 minute newsletter with fresh takes on the top-rated investments and key startup trends you should know.

We care about the protection of your data. Read our Privacy Policy.